Kevin Garey

Professor of Pharmacy Practice, and Robert L. Boblitt Endowed Professor of Drug Discovery · University of Houston

Credentials: · ·

History

Decoding the Clinical Impact of the Recent Evolution of Metronidazole Resistance on Clostridium Difficile Infection.
National Institute of Allergy and Infectious Diseases · R01
PI · $3.3M · Texas A&m University Health Science Ctr
2018–2028
A Serological Assay for Neutralizing Antitoxin Response in Patients with Clostridioides Difficile Infection (Phase II)
National Institute of Allergy and Infectious Diseases · R44
PI · $2.9M · Fzata, Inc.
2018–2026
Vancomycin Susceptibility Measures to Evaluate C. difficile Infection Outcomes
National Institute of Allergy and Infectious Diseases · R03
Contact PI · $156.4K · University of Houston
2024–2025
Decoding Antibiotic-Induced Susceptibility to Clostridium Difficile Infection
National Institute of Allergy and Infectious Diseases · U01
PI · $7.9M · Baylor College of Medicine
2016–2022

Microbiome Effect of Omadacycline on Healthy Volunteers
Principal investigator · Completed · Phase 1
University of Houston
2020–2023